Vizimpro 15, 30 & 45 mg film-coated tablets
*Company:
Pfizer Healthcare Ireland Unlimited CompanyStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 30 January 2024
File name
AdvSPCVZ40IEclean.pdf
Reasons for updating
- Removal of Black Inverted Triangle
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
The SPC has been updated as follows:
To remove the black triangle from the SPC following approval of the renewal application granting validity for an unlimited period
Updated on 30 January 2024
File name
AdvPILVZ40IEclean.pdf
Reasons for updating
- Change to section 6 - date of revision
- Removal of Black Inverted Triangle
Updated on 14 February 2023
File name
DEC202145745_Adv SPC VZ 3_0 IE clean.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 23 July 2021
File name
DEC202145745_Adv PIL VZ 3_0 IE clean.pdf
Reasons for updating
- Change to MA holder contact details
- Change to side-effects
Updated on 21 July 2021
File name
DEC202145745_Adv PIL VZ 3_0 IE clean.pdf
Reasons for updating
- Change to MA holder contact details
Updated on 09 July 2021
File name
DEC202145745_Adv PIL VZ 3_0 IE clean.pdf
Reasons for updating
- New PIL for new product
Updated on 09 July 2021
File name
DEC202145745_Adv SPC VZ 3_0 IE clean.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
|
The SPC has been updated as follows: Section 5.1 ATC code updated |
Updated on 28 January 2021
File name
DEC202105902_Adv SPC VZ 2_0 IE clean.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 5.2 - Pharmacokinetic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 20 September 2019
File name
DEC201951601_Adv SPC VZ 1_0 IE.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
SPC: New SPC to reflect the new Pfizer Marketing Authorisation
Updated on 20 September 2019
File name
DEC201951601_Adv PIL VZ 1_0 IE.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
PIL: New PIL to reflect the new Pfizer Marketing Authorisation
Pfizer Healthcare Ireland Unlimited Company
Address:
The Watermarque Building, Ringsend Road, Dublin 4, D04 K7N3, IrelandTelephone:
+353 1 467 6500Fax:
+353 1 467 6501Website:
https://www.pfizermedicalinformation.ie/Medical Information Direct Line:
1 800 633 363